TL;DR
Get wellness gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Altro Health has raised $7 million in seed funding for its platform, which lets gyms, personal trainers and medspas offer lab testing and clinician-prescribed treatments under their own brands. The company says more than 500 businesses use the service; funding will support product development, hiring and sales and marketing.
Altro Health has raised $7 million in seed funding to expand software that allows gyms, personal trainers and medspas to offer lab testing and clinician-prescribed services, including peptides, GLP-1 drugs and hormone therapy, under their own brands. The company says its platform connects wellness businesses with clinical oversight and pharmacy partners, as more fitness operators explore adding health services to their offerings.
NFX led the funding round, with participation from Founder Collective and Abby Miller Levy of Primetime Partners, according to Athletech News. Altro plans to use the money for product development, hiring, sales and marketing. The company describes its software as a way for wellness businesses to add services without building their own clinical operations.
Altro says its board-certified clinical team supervises each service and that products are supplied by licensed 503A and 503B pharmacies. Participating businesses retain their own branding and client relationships. The company says a business can begin offering services in as few as two days, though the report does not specify what steps or approvals that timeline includes.
The platform’s listed pricing starts at $319 per month, billed quarterly, for a Starter plan that includes a co-branded storefront, patient portal, product catalog, lab testing and price-setting. A Pro plan costs $599 per month and adds a storefront on the business’s own domain, marketing tools, premium lab panels with mobile blood draws and priority support. Altro says it already serves more than 500 businesses; that figure is the company’s reported customer count, not an independently audited measure.
Fitness Businesses Add Clinical Services
The funding supports a business model that places health-related services inside fitness and wellness businesses, rather than limiting access to dedicated clinics or direct-to-consumer providers. For gyms and trainers, a platform that supplies storefronts, clinical supervision and pharmacy connections could lower the operational barriers to adding services. For customers, it could mean more ways to encounter testing and prescription offerings through providers they already know.
The expansion also makes clinical oversight, prescribing practices and customer trust central questions. Altro says clinicians supervise services, but the source report does not describe the details of that process or how responsibilities are divided between the platform, prescribers, pharmacies and the business serving the client. The investment signals investor interest in the model; it does not, by itself, establish the safety or effectiveness of any treatment offered through it.
As an affiliate, we earn on qualifying purchases.
Gyms Move Into Health Services
Altro is entering a market where some gyms and wellness providers have already begun adding medical or prescription offerings. The report says Massachusetts gym owner Andrew Boimila offers peptides to members through provider Asher Med. UFC Gym announced a joint venture with NexGen MD Scientific in February to place clinics offering GLP-1s, hormone replacement therapy and peptides inside its studios, beginning with two California locations and planning expansion across its network over two years.
Other examples include Life Time’s Miora clinics, which the report says have offered a similar lineup since late 2023, and Recess Fitness’s RecessRx. The report also cites a New Consumer survey finding that one-third of younger consumers said they would consider peptides on the recommendation of a healthcare or wellness professional. That is a reported measure of stated interest, not evidence of treatment use or demand across all consumers.
“Direct-to-consumer brands are fighting over the same customers, so we went after something bigger.”
— Andrea Corleto, Altro Health founder and CEO
As an affiliate, we earn on qualifying purchases.
Clinical Oversight Details Remain Limited
The report does not give details on how clinicians assess patients, make prescribing decisions or monitor treatment, nor does it explain how the platform handles adverse events or verifies that each participating business meets applicable requirements. It also does not identify the specific treatments available in each location or explain whether offerings vary by state. Altro’s statements about its clinical team, pharmacy partners and business count are attributed to the company, and the source provides no independent audit of those claims.
The report also does not state the funding round’s valuation, the terms of the investment or the full size of the investor syndicate. Its account of rising consumer interest does not establish how many customers will seek these services or whether that interest will translate into sustained use.
As an affiliate, we earn on qualifying purchases.
Altro Plans Product and Sales Expansion
Altro says it will direct the seed funding toward product development, hiring and sales and marketing. The company has not provided a timeline for those plans or named specific product launches, hiring targets or sales goals in the source report. Its next measurable developments may include updates on platform features and the number of businesses using the service.
For customers and wellness operators, further detail on clinical workflows, prescribing oversight and pharmacy arrangements will help clarify how the platform operates as it grows. The source report does not give a date for additional announcements from Altro.
clinician-prescribed treatment kits
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What does Altro Health do?
Altro Health provides software that lets gyms, trainers and medspas offer lab testing and clinician-prescribed services under their own brands. The company says it supplies a clinical team and works with licensed 503A and 503B pharmacies.
How much funding did Altro raise, and who led the round?
Altro raised $7 million in seed funding. NFX led the round, which also included Founder Collective and Abby Miller Levy of Primetime Partners, according to the report.
What services can businesses offer through the platform?
The reported offerings include lab testing, peptides, GLP-1 drugs and hormone therapy. Availability may vary by business and location; the report does not provide a location-by-location service list.
What does Altro say it will do with the funding?
The company plans to spend the funding on product development, hiring, sales and marketing. It has not announced specific targets or a schedule for that work.
Source: rss
Cold & flu season Picks
humidifiers
As an affiliate, we earn on qualifying purchases.
